Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V George

Showing results (301-310 of 307) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 307 results.
The Oncologist|July 18, 2024
Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinomaGregory P Botta, Maen Abdelrahim, Ronald L Drengler, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 22, 2021
NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021Efrat Dotan, Louise C Walter, Ilene S Browner, et al.
Cancers|February 27, 2026
Utility of Circulating Tumor DNA to Assess Tumor Response in Patients with Locally Advanced Rectal Cancer Undergoing Neoadjuvant TherapySakti Chakrabarti, Stacey A Cohen, Antony Tin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 7, 2020
NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021Margaret von Mehren, John M Kane, Marilyn M Bui, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 12, 2021
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyMargaret A Tempero, Mokenge P Malafa, Mahmoud Al-Hawary, et al.
Annals of Surgery|August 7, 2025
Real-world Monitoring of ctDNA Reliably Predicts Cancer Recurrence and Treatment Efficacy in Patients with Resected Stages I-III Colon CancerStacey A Cohen, Vasily N Aushev, George Laliotis, et al.
JAMA|April 15, 2026
Intrawound Tobramycin Plus Vancomycin to Prevent Surgical Site Infection in Tibial Fractures: The TOBRA Randomized Clinical Trial, Robert V O'Toole, Nathan N O'Hara, et al.
Pageof 31

Showing results (301-310 of 307) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 307 results.
The Oncologist|July 18, 2024
Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinomaGregory P Botta, Maen Abdelrahim, Ronald L Drengler, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 22, 2021
NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021Efrat Dotan, Louise C Walter, Ilene S Browner, et al.
Cancers|February 27, 2026
Utility of Circulating Tumor DNA to Assess Tumor Response in Patients with Locally Advanced Rectal Cancer Undergoing Neoadjuvant TherapySakti Chakrabarti, Stacey A Cohen, Antony Tin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 7, 2020
NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021Margaret von Mehren, John M Kane, Marilyn M Bui, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 12, 2021
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyMargaret A Tempero, Mokenge P Malafa, Mahmoud Al-Hawary, et al.
Annals of Surgery|August 7, 2025
Real-world Monitoring of ctDNA Reliably Predicts Cancer Recurrence and Treatment Efficacy in Patients with Resected Stages I-III Colon CancerStacey A Cohen, Vasily N Aushev, George Laliotis, et al.
JAMA|April 15, 2026
Intrawound Tobramycin Plus Vancomycin to Prevent Surgical Site Infection in Tibial Fractures: The TOBRA Randomized Clinical Trial, Robert V O'Toole, Nathan N O'Hara, et al.
Pageof 31